WINDTREE THERAPEUTICS INC /DE/ Unrealized Gain (Loss) on Derivatives
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Unrealized Gain (Loss) on Derivatives of $613.00 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2025-11-19
- WINDTREE THERAPEUTICS INC /DE/ unrealized gain (loss) on derivatives for the quarter ending 2025-09-30 was $613.00K.
- WINDTREE THERAPEUTICS INC /DE/ unrealized gain (loss) on derivatives for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ unrealized gain (loss) on derivatives for the quarter ending 2025-03-31 was $188.00K.
- WINDTREE THERAPEUTICS INC /DE/ unrealized gain (loss) on derivatives for the quarter ending 2024-12-31 was $48.00K.
- WINDTREE THERAPEUTICS INC /DE/ unrealized gain (loss) on derivatives for fiscal 2024 was $81.00K.
- WINDTREE THERAPEUTICS INC /DE/ unrealized gain (loss) on derivatives for fiscal 2023 was $0.00.
| Period end | Unrealized Gain (Loss) on Derivatives 3 month | Unrealized Gain (Loss) on Derivatives 6 month | Unrealized Gain (Loss) on Derivatives 9 month | Unrealized Gain (Loss) on Derivatives 12 month |
|---|---|---|---|---|
| 2025-09-30 | $613.00K 10-Q · filed 2025-11-19 | $613.00K derived: sum of 2 quarters · filed 2025-11-19 | $801.00K 10-Q · filed 2025-11-19 | $849.00K derived: sum of 4 quarters · filed 2025-11-19 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | $188.00K 10-Q · filed 2025-08-19 | $236.00K derived: sum of 3 quarters · filed 2025-08-19 | $236.00K derived: sum of 4 quarters · filed 2025-11-19 |
| 2025-03-31 | $188.00K 10-Q · filed 2025-05-15 | $236.00K derived: sum of 2 quarters · filed 2025-05-15 | $236.00K derived: sum of 3 quarters · filed 2025-11-19 | $490.00K derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-12-31 | $48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $48.00K derived: sum of 2 quarters · filed 2025-11-19 | $302.00K derived: sum of 3 quarters · filed 2025-11-19 | $81.00K 10-K · filed 2025-04-15 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-19 | $254.00K derived: sum of 2 quarters · filed 2025-11-19 | $33.00K 10-Q · filed 2025-11-19 | $254.00K derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-06-30 | $254.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | $254.00K 10-Q · filed 2025-08-19 | $254.00K derived: sum of 3 quarters · filed 2025-08-19 | $254.00K derived: sum of 4 quarters · filed 2025-08-19 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-15 | $0.00 derived: sum of 2 quarters · filed 2025-05-15 | $0.00 derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $0.00 derived: sum of 2 quarters · filed 2025-04-15 | $0.00 10-K · filed 2025-04-15 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-26 | $0.00 10-Q · filed 2024-11-26 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-19 | |||
| 2012-09-30 | -$3.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | -$5.06M 10-Q · filed 2012-11-14 | ||
| 2012-06-30 | -$1.75M 10-Q · filed 2012-08-14 | |||
| 2011-09-30 | $1.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $1.96M 10-Q · filed 2012-11-14 | ||
| 2011-06-30 | $535.00K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |